Ami Vijay Desai

12PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyAutonomic nervous systemInformation extraction and fusionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 13, 2026
A pilot study of chemoimmunotherapy in the postconsolidation setting for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology Group.

Ami V Desai, Arlene Naranjo, Brian LaBarre

|Jun 23, 2025
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Aug 05, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.

Maria E Kaufman, Omar R Vayani, Kelley Moore

|May 30, 2024
Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services Module.

Brian Furner, Alex Cheng, Ami V Desai

|Jan 31, 2023
Multimodality treatment for recurrent neuroblastoma in the central nervous system.

Ami V Desai, Lena Elmuti, Christine Cahaney

|Oct 07, 2022
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.

Benjamin J Lerman, Yimei Li, Cecilia Carlowicz

Pageof 2

Frequent Collaborators

4 joint publications

Susan L Cohn

2 joint publications

Paul M Sondel

2 joint publications

Brian D Weiss

2 joint publications

Mark A Applebaum